CTRI/2024/06/068665尚未招募1 期
Immunogenicity of two dose, two site subcutaneous anti-rabies vaccine as a pre-exposure prophylaxis in children. - nil
Maulana Azad Medical College and Lok Nayak Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children and Adolescents between 2 to 18 years presenting to Lok Nayak Hospital OPD for minor ailments.
排除标准
- •1.Children with prior rabies immunization or history of animal bite.
- •2.Children with animal bite during the study period.
- •3.Children with known chronic illnesses.
- •4.Children receiving any vaccine less than a month ago.
- •5.Children on immunosuppressive drugs
- •6.Children with known Allergy to any of the components of the vaccine.
研究者
相似试验
尚未招募
不适用
Antibody Titers of Two Dose Intradermal Pre-exposure Rabies Prophylaxis Regimen in Children with No Known Immunodeficiency Versus Children Exposed to Immunosuppressant TherapyCTRI/2022/10/046777Department Of Pediatrics
进行中（未招募）
不适用
A Phase I/II Study of Immunotherapy with Subcutaneous Administered Veltuzumab (hA20) in Patients with CD20+ Non-Hodgkin's Lymphoma or Chronic Lyphocytic LeukemiaEUCTR2008-000434-47-FRImmunomedics, Inc.46
已完成
3 期
Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in IndiaCTRI/2015/05/005770Sanofi Pasteur SA400
已完成
不适用
A Phase 2 Dose-Ranging Study of Multiple Subcutaneous Doses of LY2439821 (an Anti-IL-17 Antibody) in Patients With Active Rheumatoid Arthritis on Concomitant DMARD Therapy-M069M069PER-094-09ELI LILLY AND COMPANY,31
进行中（未招募）
不适用
A Study in Patients with Rheumatoid ArthritisMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2009-009696-34-DEEli Lilly and Company648